Category: New products
-
First Bioengineered Vein Implanted for U.S. Dialysis Patient
Yesterday, a kidney dialysis patient at Duke University Hospital in Durham, North Carolina was the first in the U.S. to receive a new bioengineered blood vessel developed by a Duke University spin-off company. The patient, a 62 year-old man from Danville, Virginia with kidney failure received in his arm the engineered blood vessel made with…
-
Non-Invasive Device Controls Robotics Devices with Thoughts
Engineers at University of Minnesota in Minneapolis developed a head cap with electrodes that captures and interprets thoughts to direct autonomous devices. The team led by biomedical engineering professor Bin He demonstrated the system with a remote-controlled flying device and published its findings yesterday in the Journal of Neural Engineering. The cap worn by the…
-
Inkjet Print Process Devised for Quantum Dot Organic LEDs
Engineers at University of Louisville in Kentucky developed a process for making organic light-emitting diodes (OLEDs) with quantum dots and applied with inkjet printing, a common manufacturing technology. The findings of the research team led by Louisville engineering professor Delaina Amos will be presented next week at the Optical Society’s Conference on Lasers and Electro-Optics…
-
Stable, Inexpensive Nanoparticle Biosensors in Development
A materials scientist at Washington University in St. Louis is developing a new class of low-cost biosensors with metal nanoparticles that can be used in point-of-care medical testing, chemical detectors, and environmental monitors. Srikanth Singamaneni, a Washington University materials science professor, received last month a five-year, $400,000 Faculty Early Career Development Award from National Science…
-
Fatigue Likely Affecting MLB Players’ Batting Performance
Neurologists and statisticians at Vanderbilt University in Nashville tested a statistical model for the 2012 season that predicted major league baseball (MLB) players’ batting judgment degrades over the course of the long season. The team led by Scott Kutscher, neurology professor at Vanderbilt, will present its findings next week at the annual meeting of the…
-
FDA Approves Robotic Device for Stroke Rehabilitation
Oregon Health and Science University in Portland reports that the Food and Drug Administration approved for marketing in the U.S. a robotics device that helps stroke patients move limbs and improve muscle function during their rehabilitation. The device was developed by Paul Cordo, a biomedical engineering professor at Oregon Health and AMES Technology, a spin-off…
-
Stem Cell Process Makes Red Blood, Platelets in Quantities
Medical and public health researchers at Boston University developed a lab process for generating from adult stem cells, unlimited quantities of red blood and platelet cells, the type of cells in donated blood. The team led by George Murphy, co-director of the university’s Center for Regenerative Medicine, published its findings online yesterday in the journal Blood…
-
Nanoparticles Designed to Form Into Tiny Drug-Catching Nets
Chemistry and medical researchers at University of California in San Diego designed round nanoscale particles to float through the bloodstream and change into net-like threads that accumulate at the site of tumors and help concentrate therapies. The team led by San Diego biochemistry professor Nathan Gianneschi appears online in this week’s issue of the journal…
-
One-Step Process Developed for Genetic Designed Bacteria
Resarchers at University of Adelaide in Australia and Stanford University in California developed a more efficient process for producing genetically designed bacteria. The team led by Adelaide biotechnology professor Keith Shearwin published its findings online earlier this month in the journal ACS Synthetic Biology (paid subscription required). Shearwin and colleagues call their process “clonetegration,” which…
-
Faster Process Developed to Find Therapeutic Antibodies
Researchers at Scripps Research Institute in La Jolla, California and Scripps Korea Antibody Institute developed a new process to more rapidly identify antibodies that target specific disease molecules. The team from the lab of Richard Lerner, an immunochemistry professor at and former director of Scripps, published its findings yesterday in the journal Chemistry & Biology…